Equities

BCAL Diagnostics Ltd

BDX:ASX

BCAL Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.11
  • Today's Change0.005 / 4.76%
  • Shares traded435.54k
  • 1 Year change+10.00%
  • Beta0.5901
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BCAL Diagnostics Limited is an Australia-based screening and diagnostic company focused on early diagnosis of breast cancer. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. It is developing diagnostic technology to assist in the early detection of breast cancer by identifying, measuring and validating specific biomarkers enriched in the patient’s blood. It is engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. Its BCAL laboratory employs liquid chromatography mass spectrometry (LCMS) platforms to build on the Company's clinical research and leverage progress. The Company’s BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring.

  • Revenue in AUD (TTM)3.05m
  • Net income in AUD-6.40m
  • Incorporated2010
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ImExHS Ltd24.68m-3.42m19.05m400.00--1.26--0.7718-0.0794-0.07940.57130.33141.1097.113.7861,692.52-15.28-22.17-20.83-29.2131.9529.75-13.85-31.201.53-4.580.0593--14.7926.48-37.97--5.61--
Lumos Diagnostics Holdings Ltd17.25m-13.32m23.86m----1.49--1.38-0.0276-0.02760.0350.02150.4264.377.02---32.88-40.29-54.62-58.0763.7749.44-77.19-151.150.6949-6.010.5314--5.6619.534.22---47.99--
Cleanspace Holdings Ltd15.72m-3.13m28.74m----1.50--1.83-0.0405-0.04050.20360.24690.57141.494.45---11.37-3.31-13.04-4.1472.2574.42-19.89-4.383.92--0.1528--30.017.2961.54---20.61--
Nova Eye Medical Ltd23.45m-8.79m35.50m130.00--1.66--1.51-0.0436-0.04360.11490.09320.77850.77447.44---29.18-15.92-36.41-18.9786.6483.45-37.49-57.511.84-19.350.1357--36.907.5442.52---18.46--
Universal Biosensors, Inc.7.08m-12.39m35.77m97.00--1.71--5.05-0.0498-0.04980.02850.07010.23010.65924.25---40.27-21.79-48.77-27.1456.9546.16-175.04-209.313.75--0.0023--46.58-37.4874.90--26.83--
BCAL Diagnostics Ltd3.05m-6.40m37.66m----3.84--12.36-0.0257-0.02570.01240.02730.2953--1.03---62.03-56.30-81.11-67.80-----210.07-235.31---128.300.1507--9.1864.04-26.44--173.87--
Curvebeam AI Ltd6.53m-23.10m38.11m50.00--1.01--5.84-0.0774-0.07740.02220.11840.10470.36242.17---37.05---59.32--46.08---353.94--1.54-14.280.2905---18.97--55.62------
Cardiex Ltd11.18m-6.77m39.71m26.00--9.72--3.55-0.0251-0.02510.05010.01390.82220.37868.61---49.77-74.03-313.68-158.8592.8685.82-60.53-152.330.9687-2.220.4859--129.8722.4464.18---13.83--
Micro-X Ltd15.22m-9.77m40.13m----2.81--2.64-0.0187-0.01870.02890.02450.53230.90865.03---34.15-39.41-48.53-50.9962.0564.09-64.15-108.201.68-38.350.2186--1.4523.439.20---26.39--
Compumedics Limited49.72m-338.00k53.29m155.00--2.8243.261.07-0.0017-0.00170.31250.10281.221.983.81320,767.80-0.829-5.06-1.73-8.7052.4351.90-0.6798-4.950.6131-0.29340.3202--17.243.6894.48---6.97--
Data as of Nov 18 2024. Currency figures normalised to BCAL Diagnostics Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.